Guanjun Cheng

5.8k citations

32 papers · 4.6k indexed · 1 hit paper · h-index 25

Impact in

Immunology top 0.5%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis

Papers in

Immunology 14
- Immunotherapy and Immune Responses 8
- Immune cells in cancer 5
- Immune Cell Function and Interaction 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
Biotechnology 5
- Cancer Research and Treatments 5

Co-authors: Steven Μ. Albelda Veena Kapoor Jing Sun Zvi G. Fridlender G. Scott Worthen Leona Ling Samuel Kim Sunil Singhal
Journals: Molecular Therapy (3 papers)Oncogene (3 papers)Cancer Research (3 papers)Journal of Molecular Neuroscience (2 papers)American Journal of Respiratory Cell and Molecular Biology (2 papers)
Partner nations: United States Israel New Zealand

In The Last Decade

Guanjun Cheng

32 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN 2009 · 2.6k citations

Peers

Countries citing papers authored by Guanjun Cheng

Since Specialization

Citations

This map shows the geographic impact of Guanjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanjun Cheng more than expected).

Fields of papers citing papers by Guanjun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanjun Cheng. The network helps show where Guanjun Cheng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guanjun Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guanjun Cheng Line = papers co-authored together Guanjun Cheng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	3,3′-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen species Pharmaceutical Biology ·Susan Lanza‐Jacoby, Guanjun Cheng	2018	18
2	Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: Role of NOX4 Biochemical and Biophysical Research Communications ·Guanjun Cheng, Susan Lanza‐Jacoby	2015	56
3	Adenoviral-Based Immunotherapy Provides Local Disease Control in an Orthotopic Murine Model of Esophageal Cancer Journal of Immunotherapy ·Jon G. Quatromoni, Jarrod D. Predina, Pratik Bhojnagarwala, Ryan Judy, Jack Jiang, Enrique Stieben, Veena Kapoor, Guanjun Cheng, Olugbenga T. Okusanya, Evgeniy Eruslanov, Sunil Singhal	2014	8
4	A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation Cancer Biology & Therapy ·Jarrod D. Predina, Brendan F. Judy, Zvi G. Fridlender, Ronald A. Sanchez, Brian Madajewski, Veena Kapoor, Guanjun Cheng, Jon G. Quatromoni, Olugbenga T. Okusanya, Sunil Singhal	2012	27
5	Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils PLoS ONE ·Zvi G. Fridlender, Jing Sun, Inbal Mishalian, Sunil Singhal, Guanjun Cheng, Veena Kapoor, Wen-Hwai Horng, Zhaojie Hou, Letícia Pires Sallet, G. Scott Worthen, Steven Μ. Albelda	2012	241
6	A Trial of Intrapleural Adenoviral-mediated Interferon-α2b Gene Transfer for Malignant Pleural Mesothelioma American Journal of Respiratory and Critical Care Medicine ·Daniel H. Sterman, Andrew R. Haas, Edmund K. Moon, 袁济民, 王祖浩, Anil Vachani, Sharyn I. Katz, Colin T. Gillespie, Guanjun Cheng, Jing Sun, Emmanouil Papasavvas, Luis J. Montaner, Daniel F. Heitjan, Leslie A. Litzky, Joseph S. Friedberg, Melissa Culligan, Carl H. June, Richard G. Carroll, Steven Μ. Albelda	2011	72
7	Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation Biochemical Pharmacology ·Jing Sun, Liang‐Chuan S. Wang, Zvi G. Fridlender, Veena Kapoor, Guanjun Cheng, Lai‐Ming Ching, Steven Μ. Albelda	2011	14
8	Pharmacologic Activation of the Innate Immune System to Prevent Respiratory Viral Infections American Journal of Respiratory Cell and Molecular Biology ·Guanjun Cheng, Jorma Mänty, Zvi G. Fridlender, Guang‐Shing Cheng, Bei Chen, Nilam S. Mangalmurti, Vassiliki Saloura, ZaiFang Yu, Veena Kapoor, Krystyna Mozdzanowska, Edmund K. Moon, Jing Sun, James L. Kreindler, Noam A. Cohen, Andrew J. Caton, Jan Erikson, Steven Μ. Albelda	2010	20
9	Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+ Cells American Journal of Respiratory Cell and Molecular Biology ·Zvi G. Fridlender, Veena Kapoor, George Buchlis, Guanjun Cheng, Jing Sun, Liang‐Chuan S. Wang, Sunil Singhal, Linda A. Snyder, Steven Μ. Albelda	2010	124
10	Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products Transfusion ·Nilam S. Mangalmurti, Shampa Chatterjee, Guanjun Cheng, Emily S. Andersen, Ivan D. Chechot, Donald L. Siegel, Ann Marie Schmidt, Steven Μ. Albelda, Janet Lee	2010	38
11	A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions Molecular Therapy ·Daniel H. Sterman, Adri Recio, Andrew R. Haas, Anil Vachani, Sharyn I. Katz, Colin T. Gillespie, Guanjun Cheng, Jing Sun, Edmund K. Moon, Miglievich Ribeiro, Xinzhong Wang, Daniel F. Heitjan, Leslie A. Litzky, Carl H. June, Robert H. Vonderheide, Richard G. Carroll, Steven Μ. Albelda	2010	101
12	CCL2 Blockade Augments Cancer Immunotherapy Cancer Research ·Zvi G. Fridlender, George Buchlis, Veena Kapoor, Guanjun Cheng, Jing Sun, Sunil Singhal, Adriana Celdrán de Castro García, Liang‐Chuan S. Wang, Daniel F. Heitjan, Linda A. Snyder, Steven Μ. Albelda	2009	151
13	Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy Cancer Research ·Samuel Kim, George Buchlis, Zvi G. Fridlender, Jing Sun, Veena Kapoor, Guanjun Cheng, Andrew R. Haas, Hung Kam Cheung, Xiamei Zhang, Michael J. Corbley, Larry R. Kaiser, Leona Ling, Steven Μ. Albelda	2008	71
14	Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury American Journal of Physiology-Lung Cellular and Molecular Physiology ·James Lee, Faiz Y. Bhora, Jing Sun, Guanjun Cheng, Evguenia Arguiri, Charalambos Solomides, Shampa Chatterjee, Melpo Christofidou‐Solomidou	2007	54
15	Role of pescadillo in the transformation and immortalization of mammalian cells Oncogene ·Arianna Maiorana, Xiao Tu, Guanjun Cheng, Renato Baserga	2004	32
16	Tumor Necrosis Factor α Increases Neuronal Vulnerability to Excitotoxic Necrosis by Inducing Expression of the AMPA–Glutamate Receptor Subunit GluR1 via an Acid Sphingomyelinase- and NF-κB-Dependent Mechanism Neurobiology of Disease ·ZaiFang Yu, Guanjun Cheng, Xiaoming Wen, Gary D. Wu, Wang‐Tso Lee, David Pleasure	2002	69
17	Role of cAMP, PKA and Rap1A in thyroid follicular cell survival Oncogene ·Arturo P. Saavedra, Oxana M. Tsygankova, Gregory V. Prendergast, Tilloev, Guanjun Cheng, Judy L. Meinkoth	2002	43
18	Phosphatidylinositol-3-Kinase–Akt Kinase and p42/p44 Mitogen-Activated Protein Kinases Mediate Neurotrophic and Excitoprotective Actions of a Secreted Form of Amyloid Precursor Protein Experimental Neurology ·Guanjun Cheng, ZaiFang Yu, Daohong Zhou, Mark P. Mattson	2002	68
19	Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells Oncogene ·Guanjun Cheng, Judy L. Meinkoth	2001	19
20	Neuroprotective Role for the p50 Subunit of NF-κB in an Experimental Model of Huntington's Disease Journal of Molecular Neuroscience ·ZaiFang Yu, Daohong Zhou, Guanjun Cheng, Mark P. Mattson	2000	63

About Guanjun Cheng

Guanjun Cheng is a scholar working on Immunology, Biotechnology, Oncology, Toxicology and Virology, having authored 32 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (5 papers), Virus-based gene therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Cell death mechanisms and regulation (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (1.9k citations), Cancer Research (414 citations), Biotechnology (222 citations) and Neurology (195 citations). Guanjun Cheng has collaborated with scholars based in United States, Israel and New Zealand. Frequent co-authors include Steven Μ. Albelda, Veena Kapoor, Jing Sun, Zvi G. Fridlender, G. Scott Worthen, Leona Ling, Samuel Kim, Sunil Singhal, Daohong Zhou and Mark P. Mattson. Their work appears in journals such as Molecular Therapy, Oncogene, Cancer Research, Journal of Molecular Neuroscience and American Journal of Respiratory Cell and Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact